Remedium Lifecare Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 857841,
    "name": "Remedium Life",
    "stock_name": "Remedium Life",
    "full_name": "Remedium Lifecare Ltd",
    "name_url": "stocks-analysis/remedium-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.88",
    "chg": 0.02,
    "chgp": "2.33%",
    "dir": 1,
    "prev_price": "0.86",
    "mcapval": "77.62 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539561,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE549S01036",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "47.81 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/remedium-life-857841-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Remedium Life?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-remedium-life-3726424",
        "imagepath": "",
        "date": "2025-11-24 23:25:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Overview</strong></p>\n<p>For the year ended 31 March 2025, Remedium Life reported total operating income of ₹405.25 crores, entirely derived from net sales, with no other operating income recorded. Despite this revenue base, the company faced substantial expenditure, notably a purchase of finished goods amounting to ₹534.28 crores, which exceeded its sales figure, indicating a high cost structure. The inventory adjustment showed a negative figure of ₹136.15 crores, reflecting an increase in stock levels during the period.</p>\n<p>Operating expenses beyond purchases were minimal, with employee costs at ₹0.76 crores and other expenses totalling ₹7.44 crores. The total expenditure excluding depreciation stood at ₹406.34 crores, marginally surpassing operating income, re..."
      },
      {
        "title": "Are Remedium Life latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-remedium-life-latest-results-good-or-bad-3726169",
        "imagepath": "",
        "date": "2025-11-24 19:11:03",
        "description": "Remedium Lifecare's latest financial results for Q2 FY26 present a mixed picture, highlighting both notable achievements and significant concerns. The company reported a net profit of ₹8.62 crores, reflecting a substantial quarter-on-quarter increase of 85.38%. However, this improvement is overshadowed by a decline in net sales, which totaled ₹111.06 crores, down 2.04% from the previous quarter. This decline in sales continues a troubling trend, as it follows a much larger drop in the prior quarter and is significantly lower than the sales figures from earlier quarters.\n\nThe operating profit margin, excluding other income, improved to 6.64% from a previous low of 1.65%, suggesting some progress in cost management. Nevertheless, the reliance on non-operating income, which constituted approximately 30.61% of the operating profit, raises questions about the sustainability of this profitability. The company’s b..."
      },
      {
        "title": "Remedium Lifecare Q2 FY26: Profitability Surge Masks Deeper Structural Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/remedium-lifecare-q2-fy26-profitability-surge-masks-deeper-structural-concerns-3726156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RemediumLifecar_quaterlyResult_3726156.png",
        "date": "2025-11-24 16:52:04",
        "description": "Remedium Lifecare Ltd., a micro-cap trading and distribution company, reported a striking 85.38% quarter-on-quarter surge in net profit to ₹8.62 crores for Q2 FY26, recovering from the ₹4.65 crores recorded in Q1 FY26. However, the apparent profitability improvement belies fundamental weaknesses that have driven the stock down 69.42% over the past year, with shares currently trading at ₹1.27—a far cry from the 52-week high of ₹4.28."
      },
      {
        "title": "How has been the historical performance of Remedium Life?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-remedium-life-3704026",
        "imagepath": "",
        "date": "2025-11-15 00:22:30",
        "description": "Answer:\nThe historical performance of Remedium Life shows a total operating income of 405.25 Cr for the year ending March 2025, with a total expenditure of 406.34 Cr, resulting in an operating profit (PBDIT) of -1.09 Cr. After accounting for other income of 10.80 Cr, the operating profit stands at 9.71 Cr. The profit before tax is reported at 4.38 Cr, leading to a profit after tax of 2.13 Cr. The earnings per share (EPS) is 0.04, with a profit after tax margin of 0.53%. The company has no long-term borrowings and total liabilities amounting to 1,720.31 Cr, while total assets are equal to the same figure. The cash flow from operating activities is negative at -1,134.00 Cr, but cash flow from financing activities shows a positive inflow of 1,136.00 Cr, resulting in a net cash inflow of 1.00 Cr.\n\nBreakdown:\nRemedium Life's financial results for March 2025 indicate a total operating income of 405.25 Cr, with ex..."
      }
    ],
    "total": 500,
    "sid": "857841",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/remedium-lifecare-857841"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "20-Jan-2026",
      "details": "Submission of Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "22-Dec-2025",
      "details": "Intimation of closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "08-Dec-2025",
      "details": "Submission of postal ballot results and scrutinizer report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>1:5</strong> stock split, ex-date: 23 Feb 24",
          "dt": "2024-02-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 05 Jul 24",
          "dt": "2024-07-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Remedium Lifecare Ltd has announced <strong>61:50</strong> rights issue, ex-date: 15 Apr 25",
          "dt": "2025-04-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

How has been the historical performance of Remedium Life?

2025-11-24 23:25:17

Revenue and Profitability Overview For the year ended 31 March 2025, Remedium Life reported total operating income of ₹405.25 crores, entirely derived from net sales, with no other operating income recorded. Despite this revenue base, the company faced substantial expenditure, notably a purchase of finished goods amounting to ₹534.28 crores, which exceeded its sales figure, indicating a high cost structure. The inventory adjustment showed a negative figure of ₹136.15 crores, reflecting an increase in stock levels during the period. Operating expenses beyond purchases were minimal, with employee costs at ₹0.76 crores and other expenses totalling ₹7.44 crores. The total expenditure excluding depreciation stood at ₹406.34 crores, marginally surpassing operating income, re...

Are Remedium Life latest results good or bad?

2025-11-24 19:11:03

Remedium Lifecare's latest financial results for Q2 FY26 present a mixed picture, highlighting both notable achievements and significant concerns. The company reported a net profit of ₹8.62 crores, reflecting a substantial quarter-on-quarter increase of 85.38%. However, this improvement is overshadowed by a decline in net sales, which totaled ₹111.06 crores, down 2.04% from the previous quarter. This decline in sales continues a troubling trend, as it follows a much larger drop in the prior quarter and is significantly lower than the sales figures from earlier quarters. The operating profit margin, excluding other income, improved to 6.64% from a previous low of 1.65%, suggesting some progress in cost management. Nevertheless, the reliance on non-operating income, which constituted approximately 30.61% of the operating profit, raises questions about the sustainability of this profitability. The company’s b...

Remedium Lifecare Q2 FY26: Profitability Surge Masks Deeper Structural Concerns

2025-11-24 16:52:04

Remedium Lifecare Ltd., a micro-cap trading and distribution company, reported a striking 85.38% quarter-on-quarter surge in net profit to ₹8.62 crores for Q2 FY26, recovering from the ₹4.65 crores recorded in Q1 FY26. However, the apparent profitability improvement belies fundamental weaknesses that have driven the stock down 69.42% over the past year, with shares currently trading at ₹1.27—a far cry from the 52-week high of ₹4.28.

How has been the historical performance of Remedium Life?

2025-11-15 00:22:30

Answer: The historical performance of Remedium Life shows a total operating income of 405.25 Cr for the year ending March 2025, with a total expenditure of 406.34 Cr, resulting in an operating profit (PBDIT) of -1.09 Cr. After accounting for other income of 10.80 Cr, the operating profit stands at 9.71 Cr. The profit before tax is reported at 4.38 Cr, leading to a profit after tax of 2.13 Cr. The earnings per share (EPS) is 0.04, with a profit after tax margin of 0.53%. The company has no long-term borrowings and total liabilities amounting to 1,720.31 Cr, while total assets are equal to the same figure. The cash flow from operating activities is negative at -1,134.00 Cr, but cash flow from financing activities shows a positive inflow of 1,136.00 Cr, resulting in a net cash inflow of 1.00 Cr. Breakdown: Remedium Life's financial results for March 2025 indicate a total operating income of 405.25 Cr, with ex...

View All News